Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay

International Journal of Clinical Oncology

Volumn 12, Issue 1, 2007, Pages 42-47

  Amano, Morikazu ^a   Suzuki, Minoru ^b   Andoh, Satoshi ^c   Monzen, Hajime ^d   Terai, Kaoru ^e   Williams, Brent ^e   Song, Chang W ^e   Mayo, Kevin H ^f   Hasegawa, Takeo ^g   Dings, Ruud P M ^e,f   Griffin, Robert J ^e  

^a Kakegawa City General Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d OTSU RED CROSS HOSPITAL   (Japan)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f University of Minnesota   (United States)

^g SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Anginex; Angiogenesis; Radiation therapy

Indexed keywords

ANGINEX; ANGIOGENESIS INHIBITOR; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR REGRESSION;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; COMBINED MODALITY THERAPY; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PROTEINS; SKIN; TIME FACTORS; TUMOR BURDEN; TUMOR CELLS, CULTURED; VASCULAR NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33947512932     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0625-y     Document Type: Article

References (22)

1. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31
2. AW Griffioen G Molema 2000 Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular disease, and chronic inflammation Pharmacol Rev 52 237 268
3. J Folkman M Klagsbrun 1987 Angiogenic factors Science 235 442 447
4. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364
5. WJ Kim JW Yockman M Lee 2005 Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis J Control Release 106 224 234
6. HI Ma SZ Lin YH Chiang 2002 Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector Gene Ther 9 2 11
7. MS O'Reilly L Holmgren Y Shing 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 315 328
8. SK Gupta JP Singh 1994 Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression J Cell Biol 127 1121 1127
9. SS Tolsma OV Volpert DJ Good 1993 Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity J Cell Biol 122 497 511
10. AD Luster SM Greenberg P Leder 1995 The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation J Exp Med 182 219 231
11. DW van der Schaft EA Toebes JR Haseman 2000 Bactericidal/permeability- increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells Blood 96 176 181
12. RP Dings DW van der Schaft B Hargittai 2003 Anti-tumor activity of the novel angiogenesis inhibitor anginex Cancer Lett 194 55 66
13. RJ Griffin BW Williams R Wild 2002 Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res 62 1702 1706
14. KH Mayo DW van der Schaft AW Griffioen 2001 Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells Angiogenesis 4 45 51
15. AW Griffioen DW van der Schaft AF Barendsz-Janson et al 2001 Anginex, a designed peptide that inhibits angiogenesis Biochem J 354 233 242
16. RP Dings Y Yokoyama S Ramakrishnan 2003 The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin Cancer Res 63 382 385
17. DW van der Schaft RP Dings QG de Lussanet 2002 The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models FASEB J 16 1991 1993
18. RP Dings MM Arroyo NA Lockwood 2003 β-Sheet is the bioactive conformation of the antiangiogenic anginex peptide Biochem J 373 281 288
19. RP Dings BW Williams CW Song 2005 Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells Int J Cancer 115 312 319
20. JA Raleigh SC Chou GE Arteel 1999 Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors Radiat Res 151 580 589
21. T Akimoto NR Hunter L Buchmiller 1999 Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas Clin Cancer Res 5 2884 2890
22. R Murata Y Nishimura M Hiraoka 1997 An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma Int J Radiat Oncol Biol Phys 37 1107 1113